Patent ID: 6699656
Filing Date: 2004-03-02
Classification: A61K,A61P,C07K,Y10S

Abstract:
A method of screening a preparation comprising an isolated peptide consisting essentially of a &bgr;-hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, 21, 22 and 24, respectively), wherein said segment is not flanked by natively occurring &bgr;-hCG sequences for anti-HIV activity comprising assaying said preparation for the ability to inhibit HIV replication or expression of HIV RNA or protein.